Min Deng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Radiofrequency Ablation

Top Venues

Journal of oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Min Deng, Chong Zhong, Dong Li, Renguo Guan, Carol Lee, Huanwei Chen, Wei Qin, Hao Cai, Rongping Guo, Zubing Chen
Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: A multicenter cohort study. International journal of surgery (London, England) (2024)
Min Deng, Shaohua Li, Wei Wei, Rong-Ping Guo
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and liver 17 (2) (2023)
Min Deng, Shaohua Li, Wei Wei, Rong-Ping Guo
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and liver 17 (2) (2023)
Min Deng, Shaohua Li, Wei Wei, Rong-Ping Guo
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and liver (2023)
Min Deng, Shaohua Li, Wei Wei, Rong-Ping Guo
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Gut and liver 17 (2) (2023)
Min Deng, Lin Fang, Shao-Hua Li, Rong-Ce Zhao, Jie Mei, Jing-Wen Zou, Wei Wei, Rong-Ping Guo
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma. Mutagenesis 36 (5) (2022)
Shaohua Li, Min Deng, Qiaoxuan Wang, Jie Mei, Jingwen Zou, Wenping Lin, Ming Shi, Minshan Chen, Wei Wei, Rong-Ping Guo
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma. Journal of oncology 2022 (2022)
Shao-Hua Li, Jie Mei, Yuan Cheng, Qiang Li, Qiao-Xuan Wang, Chong-Kai Fang, Qiu-Cheng Lei, Hua-Kun Huang, Ming-Rong Cao, Rui Luo, Jing-Duo Deng, Yu-Chuan Jiang, Rong-Ce Zhao, Liang-He Lu, Jing-Wen Zou, Min Deng, Wen-Ping Lin, Ren-Guo Guan, Yu-Hua Wen, Ji-Bin Li, Lie Zheng, Zhi-Xing Guo, Yi-Hong Ling, Huan-Wei Chen, Chong Zhong, Wei Wei, Rong-Ping Guo
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Min Deng, Shaohua Li, Jie Mei, Wenping Lin, Jingwen Zou, Wei Wei, Rong-Ping Guo
High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma. Genes 12 (6) (2021)
Min Deng, Shao-Hua Li, Xu Fu, Xiao-Peng Yan, Jun Chen, Yu-Dong Qiu, Rong-Ping Guo
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients. Cancer cell international 21 (1) (2021)